ST
LUMO

Sphinx Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sphinx Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-722
Closed -$356K – 138
2015
Q1 		$356K Buy
+722
New +$280K 0.5% 28

Other funds holding LUMO

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Sphinx Trading's LUMO Position: Q4 2021 in Review

Sphinx Trading held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q4 2021 at 277 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

Sphinx Trading first reported a position in LUMO in Q1 2015 and has held it in 7 quarters since. The position peaked at $56K in Q2 2016. 38 funds tracked by Wall St. Rank hold LUMO as of Q4 2021.

  • Sphinx Trading held 277 shares of Lumos Pharma, Inc. Common Stock worth $2K as of Q4 2021.
  • Sphinx Trading left its Lumos Pharma, Inc. Common Stock share count unchanged in Q4 2021.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Sphinx Trading's portfolio in Q4 2021, its #141 holding.
  • Sphinx Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and has held it in 7 quarters since.
  • Sphinx Trading's Lumos Pharma, Inc. Common Stock position peaked at $56K in Q2 2016.
  • 38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.